...
【24h】

Differential clinical significance of COL COL 5A1 and COL COL 5A2 in tongue squamous cell carcinoma

机译:Col Col 5A1和Col Col 5A2在舌鳞状细胞癌中的差异临床意义

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background Type V collagen ( COL 5), in the functional heterotrimer [α1(V) 2 α2(V)] isoform, participates in the malignancies of various cancers. However, its role in tongue squamous cell carcinoma ( TSCC ) remains unclear. Materials and Methods The expression levels of COL 5A1 and COL 5A2 polypeptide chains were examined using the tissue microarray from 245 TSCC patients with immunohistochemistry. Paired t test and Wilcoxon signed‐rank test were performed for comparisons among the groups. Survival rates were estimated by using the Kaplan‐Meier method and compared with log‐rank tests. A Cox proportional hazards model was used to evaluate the impact of protein expression level on survival rate. Results Expression level of COL 5A1 was significantly increased in tumor tissues ( P? ? 0.001) compared to that in corresponding adjacent normal tissues. High expression level of COL 5A1 was associated with advanced pathological stage ( III , IV , P? = ? 0.015) and lymph node metastasis ( P? = ? 0.005) of TSCC patients. High expression level of COL 5A1 was also correlated with poor disease‐specific survival ( DSS , P? = ? 0.001) and disease‐free survival ( DFS , P? = ? 0.003) in TSCC patients. However, high expression level of COL 5A2 was correlated with better DFS in TSCC patients ( P? = ? 0.043). Moreover, co‐expression level of high ( COL 5A1) 2 /low ( COL 5A2) heterotrimer was correlated with worse DSS ( P ?=?0.004) and DFS ( P ?=?0.004). Conclusion COL 5A1 is an unfavorable factor for tumorigenesis, clinicopathological outcomes, and prognosis, whereas COL 5A2 is only a favorable factor for prognosis in TSCC . The co‐expression of high ( COL 5A1)2/low ( COL 5A2) heterotrimer is a more potential unfavorable factor for prognosis in TSCC .
机译:摘要背景型V胶原蛋白(COL 5),在功能异质氧化体[α1(v)2α2(v)]同种型,参与各种癌症的恶性肿瘤。然而,它在舌鳞状细胞癌(TSCC)中的作用仍然不清楚。材料和方法使用来自245SCCC患者免疫组化的组织微阵列检查COL 5A1和CHOL 5A2多肽链的表达水平。对组的比较进行配对T试验和Wilcoxon签名调查。使用Kaplan-Meier方法估计生存率并与日志排名测试进行比较。使用COX比例危害模型来评估蛋白质表达水平对存活率的影响。结果在相应的相应正常组织中的肿瘤组织中,COL 5a1的表达水平显着增加(p≤≤0.001)。 COL 5A1的高表达水平与晚期病理阶段(III,IV,P?= 0.015)和TSCC患者的淋巴结转移(P?= 0.005)。 COL 5A1的高表达水平也与TSCC患者的无疾病特异性存活(DSS,P?= 0.001)和无病的存活(DFS,P?0.003)相关。然而,COL 5A2的高表达水平与TSCC患者的更好DFS相关(P?= 0.043)。此外,高(COL 5A1)2 /低(COL 5A2)异络剂的共表达水平与差的DSS(P≤= 0.004)和DFS(P?= 0.004)相关。结论COL 5A1是肿瘤发生,临床病理结果和预后的不利因素,而CHOR 5A2只是TSCC预后的有利因素。高(COL 5A1)2 / LOW(COL 5A2)异络剂的共表达是TSCC预后的更潜在的不利因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号